Valuation: Jianmin Pharmaceutical Group Co.,Ltd.

Market Cap 4.53B 672M 582M 544M 497M 937M 64.1B 951M 6.38B 2.5B 32.07B 2.52B 2.47B 107B P/E 2024
17.5x
P/E 2025 14.2x
Enterprise Value 3.46B 512M 443M 414M 379M 714M 48.85B 725M 4.86B 1.91B 24.44B 1.92B 1.88B 81.39B EV / Sales 2024
1.56x
EV / Sales 2025 1.21x
Free-Float
65.13%
Yield 2024
2.16%
Yield 2025 2.68%
1 day-1.96%
1 week+3.00%
Current month+4.82%
1 month+7.06%
3 months-8.88%
6 months-13.57%
Current year-11.95%
1 week 27.87
Extreme 27.87
30.44
1 month 26.84
Extreme 26.84
30.9
Current year 24.68
Extreme 24.68
35.87
1 year 24.68
Extreme 24.68
43.72
3 years 24.68
Extreme 24.68
72.3
5 years 24.68
Extreme 24.68
86.78
10 years 13.69
Extreme 13.69
86.78
Manager TitleAgeSince
President 50 2020-09-08
Director of Finance/CFO 54 2018-01-01
Compliance Officer 38 -
Director TitleAgeSince
Chairman 39 2019-09-16
Director/Board Member 55 2011-08-02
Director/Board Member 55 2013-09-05
Date Insider Type Main position Quantity % Market Cap.
12/13/21 Sell

Chairman

5,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
-1.96%+3.00%-28.69%-53.97% 672M
+3.90%+9.86%+96.91%+136.30% 1,098B
+0.99%+2.91%+51.05%+52.06% 631B
+0.78%+1.17%+25.21%+63.74% 438B
+0.01%+4.42%+51.64%+40.86% 368B
+0.51%+2.28%+32.72%+40.38% 298B
+0.53%+2.61%+9.15%+9.21% 251B
+1.52%+10.12%+44.75%+59.20% 226B
+1.23%+0.76%-3.92%-50.06% 209B
-0.11%+1.46%+11.43%+66.32% 165B
Average +0.21%+1,491.83%+29.02%+36.41% 368.5B
Weighted average by Cap. +0.34%+1,331.26%+52.07%+68.83%

Financials

2024 2025
Net sales 3.5B 519M 450M 420M 384M 724M 49.55B 735M 4.93B 1.93B 24.79B 1.95B 1.91B 82.55B 3.37B 499M 432M 404M 369M 696M 47.64B 707M 4.74B 1.86B 23.83B 1.88B 1.83B 79.37B
Net income 362M 53.68M 46.47M 43.44M 39.7M 74.81M 5.12B 75.98M 509M 200M 2.56B 202M 197M 8.53B 360M 53.33M 46.17M 43.16M 39.44M 74.33M 5.09B 75.49M 506M 199M 2.54B 200M 196M 8.48B
Net Debt -942M -140M -121M -113M -103M -195M -13.31B -198M -1.32B -520M -6.66B -524M -513M -22.18B -1.08B -160M -138M -129M -118M -223M -15.25B -226M -1.52B -595M -7.63B -600M -587M -25.4B
Logo Jianmin Pharmaceutical Group Co.,Ltd.
Jianmin Pharmaceutical Group Co Ltd, formerly Wuhan Jianmin Pharmaceutical Groups Co Ltd, is a China-based company principally engaged in the research and development, manufacturing, wholesale and retail of pharmaceuticals. The Company operates its businesses through two segments. The Pharmaceutical Production and Sales segment is primarily engaged in the production of various types of Chinese patent medicines and sales to pharmaceutical distributors at all levels, including sales to the commercial division within the group that sells to non-hospitals. The Commercial segment is primarily engaged in the purchase of drugs from manufacturers and manufacturers' agents, and then distribution to lower-level distributors, sales to hospitals and retail sales in pharmacies. The Company mainly operates its businesses in the domestic market.
Employees
2,257
Date Price Change Volume
26-08-10 CN¥29.56 -1.96% 3,800,549
26-08-07 CN¥30.15 +0.53% 6,366,380
26-08-06 CN¥29.99 +6.88% 8,072,698
26-08-05 CN¥28.06 -1.82% 3,599,413
26-08-04 CN¥28.58 -0.42% 2,805,986

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600976 Stock